Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Can Untreated Pku Patients Escape From Intellectual Disability? a Systematic Review Publisher Pubmed



Van Vliet D1 ; Van Wegberg AMJ1, 2 ; Ahring K3 ; Bikmultanowski M4 ; Blau N5 ; Bulut FD6 ; Casas K7 ; Didycz B4 ; Djordjevic M8 ; Federico A9 ; Feillet F10 ; Gizewska M11 ; Gramer G12 ; Hertecant JL13 Show All Authors
Authors
  1. Van Vliet D1
  2. Van Wegberg AMJ1, 2
  3. Ahring K3
  4. Bikmultanowski M4
  5. Blau N5
  6. Bulut FD6
  7. Casas K7
  8. Didycz B4
  9. Djordjevic M8
  10. Federico A9
  11. Feillet F10
  12. Gizewska M11
  13. Gramer G12
  14. Hertecant JL13
  15. Hollak CEM14
  16. Jorgensen JV15
  17. Karall D16
  18. Landau Y17
  19. Leuzzi V18
  20. Mathisen P19
  21. Moseley K20
  22. Mungan NO6
  23. Nardecchia F18
  24. Ounap K21
  25. Powell KK22
  26. Ramachandran R23
  27. Rutsch F24
  28. Setoodeh A25
  29. Stojiljkovic M26
  30. Trefz FK5
  31. Usurelu N27
  32. Wilson C28
  33. Van Karnebeek CD29, 30
  34. Hanley WB31
  35. Van Spronsen FJ1
Show Affiliations
Authors Affiliations
  1. 1. University of Groningen, University Medical Center Groningen, Beatrix Children's Hospital, Groningen, RB, 9700, Netherlands
  2. 2. Department of Gastroenterology, Radboud University Medical Center, Nijmegen, Netherlands
  3. 3. Department of PKU, Kennedy Center, Copenhagen University Hospital, Glostrup, Denmark
  4. 4. University Children's Hospital, Jagiellonian University, Krakow, Poland
  5. 5. Dietmar-Hopp Metabolic Center, University Children's Hospital, Heidelberg, Germany
  6. 6. Department of Pediatrics, Cukurova University, Faculty of Medicine, Adana, Turkey
  7. 7. Medical Genetics, Sanford Health, Fargo, ND, United States
  8. 8. Mother and Child Health Care Institute of Serbia Dr Vukan Cupic, School of Medicine, University of Belgrade, Belgrade, Serbia
  9. 9. Department of Medical, Surgical and Neurological Sciences, Medical School, University of Siena, Policlinico Santa Maria Alle Scotte, Siena, Italy
  10. 10. Department of Pediatrics, Hopital d'Enfants Brabois, CHU Nancy, Vandoeuvre les Nancy, France
  11. 11. Dept. of Pediat., Endocrinol., Diabetology, Metab. Diseases and Cardiology of the Developmental Age, Pomeranian Medical University, Szczecin, Poland
  12. 12. Department of General Pediatrics, Division of Neuropediatrics and Metabolic Medicine, Center for Pediatric and Adolescent Medicine, University Hospital Heidelberg, Heidelberg, Germany
  13. 13. Department of Pediatrics, Tawam Hospital, Al-Ain, United Arab Emirates
  14. 14. Department of Internal Medicine, Division of Endocrinology and Metabolism, Academic Medical Center, Amsterdam, Netherlands
  15. 15. Department of Pediatrics, Oslo University Hospital, Oslo, Norway
  16. 16. Clinic for Pediatrics, Inherited Metabolic Disorders, Medical University of Innsbruck, Innsbruck, Austria
  17. 17. Metabolic Disease Unit, Sheba Medical Center, Edmond and Lily Safra Children's Hospital, Tel Aviv, Israel
  18. 18. Department of Pediatrics, Child Neurology and Psychiatry, Sapienza University of Rome, Rome, Italy
  19. 19. Department of Internal Medicine, Oslo University Hospital, Oslo, Norway
  20. 20. Genetics Division, Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States
  21. 21. Department of Clinical Genetics, United Laboratories, Tartu University Hospital, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia
  22. 22. Department of Genetics and Metabolism, Chapel Hill Hospital, University of North Carolina, Chapel Hill, United States
  23. 23. Department of Chemical Pathology and Metabolic Medicine, Guys and St Thomas' Hospitals NHS Foundation Trust, London, United Kingdom
  24. 24. Department of General Pediatrics, Muenster University Children's Hospital, Muenster, Germany
  25. 25. Department of Pediatrics, Tehran University of Medical Sciences, Tehran, Iran
  26. 26. Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia
  27. 27. Institute of Mother and Child, Centre of Reproductive Health and Medical Genetics, Chisinau, Moldova
  28. 28. Newborn Metabolic Screening Unit, LabPlus, Auckland City Hospital, Auckland, New Zealand
  29. 29. Departments of Pediatrics and Clinical Genetics, Academic Medical Centre, Emma Children's Hospital, Amsterdam, Netherlands
  30. 30. Department of Pediatrics, Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, Canada
  31. 31. Clinical and Biochemical Genetics, Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Canada

Source: Orphanet Journal of Rare Diseases Published:2018


Abstract

Background: Phenylketonuria (PKU) is often considered as the classical example of a genetic disorder in which severe symptoms can nowadays successfully be prevented by early diagnosis and treatment. In contrast, untreated or late-treated PKU is known to result in severe intellectual disability, seizures, and behavioral disturbances. Rarely, however, untreated or late-diagnosed PKU patients with high plasma phenylalanine concentrations have been reported to escape from intellectual disability. The present study aimed to review published cases of such PKU patients. Methods: To this purpose, we conducted a literature search in PubMed and EMBASE up to 8th of September 2017 to identify cases with 1) PKU diagnosis and start of treatment after 7 years of age; 2) untreated plasma phenylalanine concentrations ≥1200 μmol/l; and 3) IQ ≥80. Literature search, checking reference lists, selection of articles, and extraction of data were performed by two independent researchers. Results: In total, we identified 59 published cases of patients with late-diagnosed PKU and unexpected favorable outcome who met the inclusion criteria. Although all investigated patients had intellectual functioning within the normal range, at least 19 showed other neurological, psychological, and/or behavioral symptoms. Conclusions: Based on the present findings, the classical symptomatology of untreated or late-treated PKU may need to be rewritten, not only in the sense that intellectual dysfunction is not obligatory, but also in the sense that intellectual functioning does not (re)present the full picture of brain damage due to high plasma phenylalanine concentrations. Further identification of such patients and additional analyses are necessary to better understand these differences between PKU patients. © 2018 The Author(s).